Intrinsic Value of S&P & Nasdaq Contact Us

Plus Therapeutics, Inc. PSTV NASDAQ

NASDAQ Capital Marke • Healthcare • Biotechnology • US • USD

SharesGrow Score
40/100
1/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$1.00
-82.3%

Plus Therapeutics, Inc. (PSTV) has 20 known insider and institutional holders on record. The largest holder is Lim Kian Thiam with 7,400,000 shares. Other notable holders include Swissquote Bank SA and PostFinance AG.

Over the last 12 months, insiders have made 19 transactions in PSTV stock — 17 buys (valued at $1.6M) and 0 sells (valued at RSU Award). Insider buying has outpaced selling during this period, which may signal confidence in the company's prospects.

PSTV Insider Ownership

Top Holder
Lim Kian Thiam
7,400,000 shares
Buys (12 mo)
17
$1.6M value
Sells (12 mo)
0
$0.00 value
12-Month Transaction Activity
Buy 89%
Sell 0%
Top Insider Holders
# Name Role Shares Owned Last Filed Relative Size
1 Lim Kian Thiam 10 Percent Owner 7,400,000 2015-04-20
100%
2 Swissquote Bank Sa 10 Percent Owner 5,416,655 2018-01-11
73%
3 Postfinance Ag 10 Percent Owner 4,543,086 2018-02-15
61%
4 Saad Mark E Chief Financial Officer 1,090,000 2014-04-15
15%
5 Shirahama Norio Seijiro President - Asia Pacific 832,500 2015-02-03
11%
6 Olympus Corp 10 Percent Owner 500,000 2008-08-11
7%
7 Hedrick Marc H Chief Executive Officer 499,468 2026-04-01
7%
8 Cox Marshall G Director 480,000 2007-02-28
6%
9 Hawkins Richard J Director 397,794 2025-08-15
5%
10 Reuter Bruce SVP Sales, Market., Distr. 394,686 2009-02-02
5%
11 Schulzki Sharon Chief Operating Officer 380,000 2005-02-04
5%
12 Van Es-johansson An Director 297,794 2025-08-15
4%
13 Clowes Howard Director 297,794 2025-08-15
4%
14 Galetto Charles Sr. Vice President Finance & A 280,000 2006-01-26
4%
15 Arm Douglas M Sr. VP - Operations 185,000 2009-05-04
3%
16 Scarbrough Elizabeth Vice President Marketing & Dev 176,250 2006-01-26
2%
17 Fraser John K Vice President Research & Tech 166,250 2005-02-04
2%
18 Scott Matthew Vice President Sales 165,000 2004-06-04
2%
19 Milstein Alexander M VP - Clinical Development 155,000 2009-02-02
2%
20 Sims Andrew John Hugh Macintyre Chief Financial Officer 144,784 2026-04-01
2%
Recent Transactions (last 12 months)
Date Name Role Type Shares Price Value
2026-04-01 Sims Andrew John Hugh Macintyre Chief Financial Officer Option Exercise 38,323 - -
2026-04-01 Hedrick Marc H Chief Executive Officer Option Exercise 159,681 - -
2026-03-20 Andrews Ronald Asbury Director Unknown - - -
2026-02-25 Sims Andrew John Hugh Macintyre Chief Financial Officer RSU Award 349,541 $0.28 $97.87K
2026-02-25 Hedrick Marc H Chief Executive Officer RSU Award 2,419,582 $0.28 $677.48K
2026-01-01 Sims Andrew John Hugh Macintyre Chief Financial Officer Option Exercise 38,323 - -
2026-01-01 Hedrick Marc H Chief Executive Officer Option Exercise 159,681 - -
2025-11-04 Sims Andrew John Hugh Macintyre Chief Financial Officer Informative Buy 20,000 $0.51 $10.2K
2025-10-01 Sims Andrew John Hugh Macintyre Chief Financial Officer Option Exercise 38,323 - -
2025-10-01 Hedrick Marc H Chief Executive Officer Option Exercise 159,681 - -
2025-08-22 Lenk Robert P Director Informative Buy 110,000 $0.49 $53.78K
2025-08-13 Clowes Howard Director RSU Award 297,794 $0.57 $171.05K
2025-08-13 Sims Andrew John Hugh Macintyre Chief Financial Officer RSU Award 459,878 - -
2025-08-13 Van Es-johansson An Director RSU Award 297,794 $0.57 $171.05K
2025-08-13 Guse Kyle Director RSU Award 40,000 $0.57 $22.98K
2025-04-18 Guse Kyle Director Unknown - - -
2025-08-13 Lenk Robert P Director RSU Award 297,794 $0.57 $171.05K
2025-08-13 Hawkins Richard J Director RSU Award 397,794 $0.57 $228.49K
2025-08-13 Hedrick Marc H Chief Executive Officer RSU Award 1,916,168 - -
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message